Advertisement

Diabetologia

, Volume 36, Issue 5, pp 397–401 | Cite as

Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus

  • E. J. Stevens
  • M. J. Lockett
  • A. L. Carrington
  • D. R. Tomlinson
Originals

Summary

In rats with 6 weeks streptozotocin-diabetes there was a 53% reduction in sciatic nerve laser Doppler flux compared to controls (p<0.01). Treatment of a parallel group of diabetic rats with evening primrose oil, by dietary admixture throughout the protocol, prevented this ischaemia (Doppler flux was 91% of evening primrose oil-treated controls and was not significantly different). There were no differences in systemic arterial pressure. In another experiment evening primrose oil markedly antagonised the development of exaggerated resistance to anoxic conduction failure in sciatic nerves from diabetic rats. The resistance to anoxia of nerves from non-diabetic rats was also reduced by evening primrose oil. These observations suggest that the sciatic nerves of diabetic rats with short-term streptozotocin-diabetes are markedly ischaemic and that this ischaemia is involved in the development of increased resistance to anoxic/ischaemic conduction failure in diabetic nerve. The findings also promote evening primrose oil as a potential treatment to prevent nerve ischaemia.

Key words

Diabetes mellitus diabetic neuropathies Doppler flux essential fatty acids gamma linolenic acid anoxia ischaemia nerve conduction rat streptozotocin 

References

  1. 1.
    Greene DA, Lattimer SA, Sima AAF (1988) Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy? Diabetes 37: 688–693Google Scholar
  2. 2.
    Greene DA, Lattimer SA, Sima AAF (1988) Pathogenesis and prevention of diabetic neuropathy. Diabetes Metab Rev 4: 201–221Google Scholar
  3. 3.
    Greene DA, Sima AAF, Pfeifer MA, Albers JW (1990) Diabetic neuropathy. Annu Rev Med 41: 303–317Google Scholar
  4. 4.
    Tuck RR, Schmelzer JD, Low PA (1984) Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107: 935–950Google Scholar
  5. 5.
    Monafo WW, Eliasson SG, Shimazaki S, Sugimoto H (1988) Regional blood flow in resting and stimulated sciatic nerve of diabetic rats. Exp Neurol 99: 607–614Google Scholar
  6. 6.
    Cameron NE, Cotter MA, Low PA (1991) Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol 261: E1-E8Google Scholar
  7. 7.
    Newrick PG, Wilson AJ, Jakubowski JA, Boulton AJM, Ward JD (1986) Sural nerve oxygen tension in diabetes. Br Med J 293: 1053–1054Google Scholar
  8. 8.
    Low PA, Schmelzer JD, Ward KK, Yao JK (1986) Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy. Am J Physiol 250: E94-E99Google Scholar
  9. 9.
    Smith WJ, Diemel LT, Leach RM, Tomlinson DR (1991) Central hypoxaemia in rats provokes neurological defects similar to those seen in experimental diabetes mellitus: evidence for a partial role of endoneurial hypoxia in diabetic neuropathy. Neuroscience 45: 255–259Google Scholar
  10. 10.
    Cameron NE, Cotter MA, Robertson S (1992) Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats. Diabetologia 35: 12–18Google Scholar
  11. 11.
    Cameron NE, Cotter MA, Ferguson K, Robertson S, Radcliffe MA (1991) Effects of chronic α-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na+-K+-ATPase activity, and vascular supply in STZ-D rats. Diabetes 40: 1652–1658Google Scholar
  12. 12.
    Julu POO (1988) Essential fatty acids prevent slowed nerve conduction in streptozotocin diabetic rats. Diab Comp 2: 185–188Google Scholar
  13. 13.
    Tomlinson DR, Robinson JP, Compton AM, Keen P (1989) Essential fatty acid treatment-effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats. Diabetologia 32: 655–659Google Scholar
  14. 14.
    Cameron NE, Cotter MA, Robertson S (1991) Essential fatty acid diet supplementation: effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats. Diabetes 40: 532–539Google Scholar
  15. 15.
    Lockett MJ, Tomlinson DR (1992) The effects of dietary treatment with essential fatty acids on sciatic nerve conduction and activity of the Na+/K+ pump in streptozotocin-diabetic rats. Br J Pharmacol 105: 355–360Google Scholar
  16. 16.
    Daube JR, Dyck PJ (1984) Neuropathy due to peripheral vascular diseases. In: Dyck PJ, Thomas RK, Lambert EH, Bunge R (eds) Peripheral neuropathy. 1st Edn. pp 1458–1478Google Scholar
  17. 17.
    Sokal RR, Rohlf FJ (1981) Biometry. 2nd edn. W. H. Freeman and Company, New YorkGoogle Scholar
  18. 18.
    Rundquist I, Smith QR, Michel ME, Ask P, Oberg PA, Rapoport SI (1985) Sciatic nerve blood flow measured by laser Doppler flowmetry and [14C]iodoantipyrine. Am J Physiol 248: 311–317Google Scholar
  19. 19.
    Low PA, Tuck RR (1984) Effects of changes of blood pressure, respiratory acidosis and hypoxia on blood flow in the sciatic nerve of the rat. J Physiol 347: 513–524Google Scholar
  20. 20.
    Sundqvist T, Oberg PA, Rapoport SI (1985) Blood flow in rat sciatic nerve during hypotension. Exp Neurol 90: 139–148Google Scholar
  21. 21.
    Manku MS (1983) A comparison of gas liquid chromatography and high performance liquid chromatography methods for determining fatty acid composition of evening primrose (Oenothere biennis) and soyabean oil. J Chromatog Sci 21: 367–369Google Scholar
  22. 22.
    Myher JJ, Marai A, Kuksis A (1977) Acylglycerol structure of peanut oils of different atherogenic potential. Lipids 12: 775–785Google Scholar
  23. 23.
    Stevens EJ, Carrington AL, Tomlinson DR (1992) Prostacyclin release in experimental diabetes: effects of evening primrose oil. Br J Pharmac 107: 276PGoogle Scholar
  24. 24.
    Horrobin DF, Manku MS, Huang YS (1984) Effects of essential fatty acids on prostaglandin biosynthesis. Biomed Biochim Acta 43: S114-S120Google Scholar
  25. 25.
    Watanabe Y, Manku MS, Jenkins DK, Mitchell JA, Horrobin DF (1987) The effects of short term dietary supplementation with evening primrose oil or safflower oil on fatty acid and prostaglandin release from perfused mesenteric vascular beds in spontaneously hypertensive rats. J Am Coll Nutr 6: 447–453Google Scholar
  26. 26.
    Horrobin DF, Durand LG, Manku MS (1977) Prostaglandin E1 modifies nerve conduction and interferes with local anaesthetic action. Prostaglandins 14: 103–108Google Scholar
  27. 27.
    Yasuda H, Sonobe M, Hatanaka I et al. (1988) A new prostaglandin E1 analogue (TFC-612) prevents a decrease in motor nerve conduction velocity in streptozocin-diabetic rats. Biochem Biophys Res Comm 150: 225–230Google Scholar
  28. 28.
    Yasuda H, Sonobe M, Yamashita M et al. (1989) Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats: comparison with aldose reductase inhibitor ONO 2235. Diabetes 38: 832–838Google Scholar
  29. 29.
    Dyck PJ (1989) Hypoxic neuropathy: does hypoxia play a role in diabetic neuropathy ·? New Engl J Med 320: 57–60Google Scholar
  30. 30.
    Cotter MA, Cameron NE, Dines KC, Maxfield F, Robertson S, Cox D (1992) The effect of evening primrose oil on nerve conduction in diabetic rats depends on product(s) of cyclooxygenase-mediated gamma-linolenic acid metabolism. Diabet Med 9 [Suppl 1] A12 (Abstract)Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • E. J. Stevens
    • 1
  • M. J. Lockett
    • 2
  • A. L. Carrington
    • 2
  • D. R. Tomlinson
    • 1
    • 2
  1. 1.William Harvey Research Institute, Queen Mary and Westfield CollegeUniversity of LondonLondonUK
  2. 2.Department of Pharmacology, Medical Sciences, Queen Mary and Westfield CollegeUniversity of LondonLondonUK

Personalised recommendations